Сравнение

Carbetocin vs. Lanreotid

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

37025-55-1

108736-35-2

Молекулярная масса

нет данных

1096.34 g/mol

Период полувыведения

0.67 h

нет данных

Последовательность

нет данных

Механизм действия

Carbetocin

Carbetocin is an oxytocin receptor agonist with prolonged duration. It triggers a sustained contraction of the uterus after birth, preventing atonic hemorrhage — unlike oxytocin, without a multi-hour infusion.

Lanreotid

Lanreotide activates somatostatin receptors (chiefly SSTR2, additionally SSTR5), thereby suppressing the release of growth hormone, IGF-1 and various gastrointestinal and neuroendocrine hormones. It is metabolically far more stable than natural somatostatin.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Carbetocin	Lanreotid
Германия	Рецептурный	Рецептурный
США	Не одобрено	Рецептурный

Полные записи

Frequently asked questions

What is the difference between Carbetocin and Lanreotid?: Carbetocin is classified as "Исследования (прочее)", while Lanreotid is classified as "Исследования (прочее)". Carbetocin: Carbetocin is a long-acting synthetic oxytocin analog (half-life ~40 minutes). It prevents postpartum hemorrhage as a single injection. Approved in Canada and the UK among others, NOT in the US. Lanreotid: Lanreotide is a synthetic cyclic octapeptide analog of somatostatin. It binds preferentially to the somatostatin receptors SSTR2 and SSTR5 and is approved for treating acromegaly and certain neuroendocrine tumours. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Carbetocin or Lanreotid?: The highest available evidence level is "РКИ на людях" for Carbetocin and "РКИ на людях" for Lanreotid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Carbetocin and Lanreotid in Germany and the United States?: Германия: Carbetocin — Рецептурный, Lanreotid — Рецептурный. США: Carbetocin — Не одобрено, Lanreotid — Рецептурный. These are factual summaries with source and review date on the individual pages.

Country

Carbetocin

Lanreotid

Германия

Рецептурный

США

Не одобрено

Рецептурный

Frequently asked questions

What is the difference between Carbetocin and Lanreotid?

Carbetocin is classified as "Исследования (прочее)", while Lanreotid is classified as "Исследования (прочее)". Carbetocin: Carbetocin is a long-acting synthetic oxytocin analog (half-life ~40 minutes). It prevents postpartum hemorrhage as a single injection. Approved in Canada and the UK among others, NOT in the US. Lanreotid: Lanreotide is a synthetic cyclic octapeptide analog of somatostatin. It binds preferentially to the somatostatin receptors SSTR2 and SSTR5 and is approved for treating acromegaly and certain neuroendocrine tumours. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Carbetocin or Lanreotid?

The highest available evidence level is "РКИ на людях" for Carbetocin and "РКИ на людях" for Lanreotid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Carbetocin and Lanreotid in Germany and the United States?

Германия: Carbetocin — Рецептурный, Lanreotid — Рецептурный. США: Carbetocin — Не одобрено, Lanreotid — Рецептурный. These are factual summaries with source and review date on the individual pages.